Product name : Fasoracetam
Other name: NS-105, LAM-105, Piperidine, 1-[[(2R)-5-oxo-2-pyrrolidinyl]carbonyl]-
(5R)-5-(piperidine-1-carbonyl) pyrrolidin-2-one
CAS Number: 110958-19-5
Molecular Formula: C10H16N2O2
Molecular Weight : 196.2484
Assay : 99.5%
Appearance: White crystalline powder
Fasoracetam: A Comprehensive Overview for Research Use
Product Name: Fasoracetam (NS-105, AEVI-001)
CAS Number: 110958-19-5
Molecular Formula: C₁₀H₁₆N₂O₂
Molecular Weight: 196.25
Purity: ≥98% (crystalline solid)
Storage: Store at -20°C, stable for ≥2 years .
Introduction
Fasoracetam, a member of the racetam family, is a research chemical initially developed by Nippon Shinyaku for dementia treatment. Although ineffective for vascular dementia , it has gained attention for its potential cognitive-enhancing properties and applications in neurological research. Current clinical trials focus on ADHD, anxiety, and memory disorders, particularly in individuals with mGluR gene mutations .
Mechanism of Action
Fasoracetam primarily acts on metabotropic glutamate receptors (mGluRs) and indirectly modulates GABA and acetylcholine systems:
- Glutamate Agonism: Enhances mGluR activity, improving synaptic plasticity and cognitive functions .
- GABA Regulation: Indirectly increases GABA synthesis by elevating glutamate availability, potentially reducing anxiety and stabilizing mood .
- Cholinergic Effects: Boosts acetylcholine release in the cerebral cortex, supporting memory and learning .
Note: Most mechanisms are derived from animal studies; human data remain limited .
Potential Benefits
- Cognitive Enhancement:
- Improves focus and memory recall in ADHD patients (400 mg/day in adolescents showed significant behavioral improvements) .
- Enhances learning capacity and mental performance in animal models .
- Mood Stabilization:
- Reduces anxiety and depression-like symptoms via GABA modulation .
- Neuroprotection:
- Prevents memory deficits induced by scopolamine or baclofen in rats .
Caution: Benefits are based on preliminary research and require further clinical validation .
Safety and Handling
- Classification: Not classified as hazardous under OSHA HCS guidelines. No GHS labeling required .
- Side Effects:Handling: Use impermeable gloves; avoid inhalation/ingestion. Collect spills mechanically to prevent environmental contamination .
- Mild: Headache, fatigue, digestive discomfort (may relate to choline depletion; consider stacking with citicoline) .
- Severe: Bradycardia (>1,000 mg/day) .
Research Applications
- ADHD and Autism: Phase 3 trials ongoing for mGluR-related ADHD (10% of cases) .
- Substance Abuse: Reduces stimulant preference in animal models, suggesting potential anti-addiction applications .
- Cognitive Disorders: Investigated for dementia, epilepsy, and schizophrenia .
Keywords
- Fasoracetam nootropic
- Cognitive enhancer for ADHD
- mGluR agonist research
- GABA modulator for anxiety
- Fasoracetam clinical trials